In addition, we found that the expression of GNA15 in AML patients with FLT3-ITD (FMS-like tyrosine kinase-3 internal tandem duplications) was significantly higher than those without FLT3-ITD. This evidence concerns the gene FLT3 and acute myeloid leukemia.